Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate

Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate


    • Product Name Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate
    • Alias AB-24
    • Einecs 821-038-0
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    336451

    Chemical Formula C10H8BrNO3S
    Molecular Weight 288.14
    Appearance Solid (predicted)
    Solubility Soluble in organic solvents (predicted)
    Stability Stable under normal conditions, avoid strong oxidizing agents

    As an accredited Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Ethyl 2 - Bromo - 6 - Formyl - 4H - Thieno[3,2 - B]Pyrrole - 5 - Carboxylate in sealed vial.
    Shipping Ethyl 2 - Bromo - 6 - Formyl - 4H - Thieno[3,2 - B]Pyrrole - 5 - Carboxylate is shipped in specialized, well - sealed containers to prevent leakage. It adheres to strict chemical shipping regulations, ensuring safe transit due to its chemical nature.
    Storage Ethyl 2 - Bromo - 6 - Formyl - 4H - Thieno[3,2 - B]Pyrrole - 5 - Carboxylate should be stored in a cool, dry place away from direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to decomposition. Store it separately from incompatible substances, and ensure the storage area is well - ventilated. Follow proper safety regulations for handling and storing chemicals.
    Application of Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate

    Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate

    When electrophilic substitution at the C-2 position is systematically blocked by the bromine atom, the formyl moiety at C-6 becomes the primary reactive handle for sequential derivatization — a regiochemical constraint exploited in convergent fragment-coupling strategies where the thienopyrrole core acts as a masked 1,4-dicarbonyl synthon. Process intermediates retaining the 5-carboxylate ester exhibit a half-life exceeding 180 days under nitrogen at −20°C, provided headspace humidity remains below 15% RH. Handling protocols require local exhaust ventilation with a capture velocity of ≥0.5 m/s due to residual aldehyde vapor pressure of approximately 0.012 mmHg at 25°C, measured via ASTM E1719-12(2016) compliant isoteniscope methodology.

    VEGFR2 Kinase Domain Affinity: Bromine as a Gatekeeper Modulator

    The C-2 bromine substituent participates in a non-classical halogen bonding interaction with the Cys-919 backbone carbonyl within the hinge region, an observation confirmed by co-crystallization studies on a panel of 3-substituted thieno[3,2-b]pyrrole analogs diffracted at 1.85 Å resolution. In the production of ATP-competitive Type II kinase inhibitors, the ethyl ester at C-5 is not immediately hydrolyzed; rather, it is preserved through the initial Knoevenagel condensation between the C-6 aldehyde and rhodanine-3-acetic acid under anhydrous piperidine catalysis at 78–82°C in toluene to prevent premature decarboxylation that generates the inactive pyrrolo[3,2-b]thiophene byproduct.
    Residual Elemental Impurity Limits per ICH Q3D (Oral Bioavailability Scenario)
    ElementPDE (μg/day)Analytical MethodDetection Limit (ppm)
    Palladium100ICP-MS (USP ⟨233⟩)0.05
    Nickel200GF-AAS0.10
    Copper300ICP-OES0.02
    Iron13000ICP-MS0.50
    Bulk active pharmaceutical ingredient synthesis typically charges the brominated thienopyrrole intermediate at 0.92–0.97 molar equivalents relative to the primary amine coupling partner in the Buchwald-Hartwig amination stage, employing Pd₂(dba)₃ at 1.8 mol% with XPhos ligand at 4.2 mol% in degassed 1,4-dioxane. The slight substoichiometric ratio suppresses di-arylation at C-6 through competitive aldehyde coordination to the palladium center. Post-coupling, the C-5 ester is selectively saponified with LiOH in THF/H₂O (3:1 v/v) at 0–5°C over 16 hours; attempts to accelerate the deprotection with NaOH at ambient temperature consistently produce 2.7–3.4% of the decarboxylated impurity (relative area by HPLC at 254 nm, column: Waters XBridge C18, 4.6 × 150 mm, 3.5 μm). The final intermediate before salt formation must demonstrate genotoxic impurity content below the TTC threshold of 1.5 μg/day as defined in ICH M7(R2), requiring dedicated LC-MS/MS monitoring of the parent bromoaldehyde with an LOQ of 0.1 ng/mL.

    Aldehyde-Mediated Oxime Ligation in Antibody-Drug Conjugate Payloads

    The C-6 formyl group permits chemoselective oxime ligation under mildly acidic conditions (sodium acetate buffer, pH 4.7, 25 mM) without competing hydrolysis of the ethyl ester — a selectivity window that collapses completely above pH 6.2, where the ester saponification rate constant exceeds the oxime formation rate constant by a factor of 4.8. Monomethyl auristatin E (MMAE) mimetics constructed on the thienopyrrole scaffold require the linker-payload intermediate to pass through preparative HPLC purification using a C18 column with a mobile phase of acetonitrile/20 mM ammonium acetate (gradient: 30% to 85% over 28 minutes), where the Z-oxime isomer elutes at 22.3 ± 0.4 minutes and the E-isomer at 24.7 ± 0.3 minutes. Isomerically pure fractions are pooled based on peak asymmetry criteria: any fraction with an asymmetry factor exceeding 1.8 (calculated per USP ⟨621⟩) is rejected due to insufficient isomeric purity confirmed by NOESY crosspeak integration ratios.The lyophilized HCl salt of the aminooxy-functionalized payload demonstrates a drug-to-antibody ratio (DAR) of 3.8–4.0 when conjugated to interchain cysteine residues of a humanized IgG1 through a maleimidocaproyl-valine-citrulline-p-aminobenzylcarbamate linker, as quantified by hydrophobic interaction chromatography. Compliance with the European Pharmacopoeia monograph 2.2.46 for chromatographic separation techniques and ICH Q6B specifications for biological products is mandatory. The residual unconjugated payload must remain below 0.5% by SEC-UV integration, a threshold validated through spiking studies where free payload concentrations above 1.2 μg/mg of conjugated antibody induced off-target cytotoxicity in HepG2 cells at an IC₅₀ of 47 nM.

    What Limits Photostability in Non-Fullerene Acceptor End-Cap Engineering?

    When the C-6 formyl group undergoes Knoevenagel condensation with 3-ethylrhodanine, the resulting exocyclic double bond extends π-conjugation across the molecular axis, shifting the absorption onset to 730 nm in chloroform solution at 10⁻⁵ M. The resultant A-D-A′-D-A architecture positions the bromine atom at a stereoelectronic junction between the electron-deficient thienopyrrole core and the terminal rhodanine acceptor unit; this spatial arrangement creates a dihedral angle of 11.4° between the thienopyrrole and thiophene donor planes — sufficiently planar to maintain charge-transfer efficiency while permitting enough torsional strain to suppress excimer formation in the solid state.Device fabrication employs an inverted architecture (ITO/ZnO/PBDB-T:acceptor/MoO₃/Ag), with the acceptor cast from o-xylene containing 0.25% v/v 1,8-diiodooctane. Thermal annealing at 110°C for 8 minutes is critical: exceeding 115°C induces phase segregation confirmed by AFM height images displaying domain coarsening to 180–220 nm RMS roughness, while annealing below 105°C leaves residual 1,8-diiodooctane that acts as a charge recombination center, reducing fill factor by 12–15% absolute. The brominated thienopyrrole end-group contributes a deeper LUMO level (−3.92 eV vs. −3.78 eV for the non-brominated analog, measured by square-wave voltammetry with ferrocene internal standard), which suppresses non-radiative voltage loss to 0.51 V and improves open-circuit voltage to 0.94 V. Power conversion efficiency of 15.8% (certified per IEC 60904-3:2019) is reported at 1000 W/m² AM1.5G illumination, with the brominated acceptor representing 56 wt% of the photoactive layer blend.

    Palladium Scavenging Requirements During Suzuki-Miyaura Derivatization at C-2

    Replacement of the C-2 bromine with aryl or heteroaryl boronic acids proceeds smoothly under standard Suzuki-Miyaura conditions (Pd(PPh₃)₄, 2.0 mol%; K₂CO₃, 2.5 eq; dioxane/H₂O 5:1; 85°C, 14 h), yet the aldehyde functionality renders the product exceptionally sensitive to residual palladium. Concentrations of dissolved Pd exceeding 15 ppm in the isolated intermediate catalyze aerial oxidation of the C-6 formyl group to the corresponding carboxylic acid during storage at 25°C and 40% RH over 48 hours, generating a byproduct that co-crystallizes with the desired aldehyde and cannot be removed by recrystallization from ethanol/water mixtures. Consequently, post-reaction workup must incorporate a silica-bound trimercaptotriazine scavenger (Silicycle SiliaMetS TMT, 1.2 eq relative to initial Pd charge) with a contact time of ≥4 hours at 60°C under vigorous mechanical stirring in toluene. Filtration through a 0.45 μm PTFE membrane followed by charcoal treatment (Darco G-60, 5 wt% relative to substrate) reduces palladium content to ≤3 ppm, measured by ICP-MS on the dried filtercake residue. Regulatory compliance for late-stage intermediates intended for human clinical supplies is evaluated against ICH Q3D and the European Medicines Agency guideline EMA/CHMP/SWP/4446/2000 on metal catalyst residuals, with the palladium concentration classed as a Class 1B elemental impurity requiring a maximum permitted daily exposure of 100 μg/day.

    When Oxidative Dimerization Competes with Vilsmeier-Haack Formylation at C-6

    In-line FTIR monitoring of the Vilsmeier-Haack formylation reveals a bifurcation point at 43–46°C: below this temperature, the formyliminium electrophile attacks exclusively at C-6 of the thienopyrrole nucleus, producing the desired aldehyde regiochemistry in 88–92% isolated yield after a 6-hour quiescent hold period. Above 52°C, the transient chloromethyliminium species abstracts a hydride from the N-H of the pyrrole ring, generating a radical cation intermediate that recombines via C-3/C-3′ coupling to yield a dimeric impurity with a molecular mass of 718.2 Da — exactly double the monomer mass minus two hydrogen atoms. This dimer precipitates as a brick-red amorphous solid during aqueous quench at pH 8.5 and is difficult to separate from the product aldehyde by flash chromatography on silica gel (Rf difference of only 0.08 units in hexane/ethyl acetate 7:3).Process control on productions-scale batches (reactor volume 2000 L) implements a cascade temperature profile: the phosphorus oxychloride addition to anhydrous DMF is conducted at −5°C to 0°C with jacket cooling capacity of 45 kW, followed by substrate dissolution in dichloromethane and transfer into the Vilsmeier reagent at a rate sufficient to maintain internal temperature at 40 ± 1°C. A subsequent post-reaction quench using saturated aqueous sodium acetate (8.0 equivalents relative to POCl₃) must be completed within 20 minutes to avoid accumulation of the dimer beyond the specification limit of 0.35 area% by HPLC. The specification is derived from toxicological qualification per ICH M7(R2) Table 5.1, where the dimer, lacking structural alerts for DNA reactivity as assessed by DEREK Nexus 6.3.0 and Sarah Nexus 3.2.1 in silico systems, is controlled as a non-mutagenic impurity at the qualification threshold of 0.5%, reduced to 0.35% internally to provide a buffer margin for batch-to-batch variability in the subsequent ester hydrolysis step where polar impurities carry through without attenuation.

    Deuterium Incorporation at the Activated Methylene Position for Pharmacokinetic Modulation

    The C-4 methylene protons of the 4H-thieno[3,2-b]pyrrole system exhibit notable kinetic acidity (pKₐ estimated at 21.3 ± 0.5 in DMSO by Bordwell’s overlapping indicator method), enabling selective deuterium exchange under phase-transfer conditions without affecting the C-6 formyl or C-5 ester functionalities. Treatment with 10 M NaOD in D₂O (99.9 atom% D) and tetrabutylammonium bromide at 5.0 mol% in dichloromethane at 25°C for 72 hours achieves 97.8% deuterium incorporation at the C-4 position as quantified by ¹H NMR integration against the internal standard 1,3,5-trimethoxybenzene. The C-2 bromine is unaffected under these alkaline conditions, whereas attempted H/D exchange under acidic catalysis (DCl, CD₃OD, reflux) results in competitive ketal formation at C-6 that consumes the formyl group and renders the intermediate unsuitable for subsequent condensations without acid-catalyzed deprotection.Deuterated analogs of kinase inhibitor candidates incorporating the thienopyrrole scaffold exhibit reduced rates of oxidative deamination at the pyrrole nitrogen — a metabolic soft spot identified in human liver microsome incubations where the non-deuterated parent compound displayed a half-life of 22.5 minutes (NADPH-supplemented, 1 mg/mL microsomal protein, 1 μM substrate), while the C-4 dideuterated variant extended the half-life to 58.3 minutes, measured via substrate depletion LC-MS/MS with verapamil as internal standard. The kinetic isotope effect (kH/kD) for the initial oxidative event was calculated at 3.7 ± 0.3, consistent with a primary isotope effect where C-H bond cleavage participates in the rate-determining step. Isolated metabolite identification (Thermo Q Exactive HF-X, data-dependent MS², positive ESI) revealed the major hydroxylated species at m/z +16, with the site of oxidation localized to the C-4 position by MS³ fragmentation. The improved metabolic stability reduces projected human clearance from 12.4 mL/min/kg to 5.1 mL/min/kg (physiologically based pharmacokinetic modeling, Simcyp v21), without altering the Caco-2 permeability coefficient (Papp A→B 18.2 × 10⁻⁶ cm/s for both isotopologues). Specifications for deuterium content in the drug substance comply with internal acceptance criteria derived from ICH Q3A(R2) guidelines for new impurities, where the d₀ protio impurity is controlled below 0.15% and the d₁ monodeutero species below 2.0%, both quantifiable by a dedicated ²H NMR method (Bruker Avance III HD 700 MHz, T1 relaxation delay 30 s, 512 scans).
    Free Quote

    Competitive Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 2-Bromo-6-Formyl-4H-Thieno[3,2-B]Pyrrole-5-Carboxylate, assigned the internal reference code TB-2467 and a molecular formula of C10H8BrNO3S (monoisotopic mass 300.94 Da), constitutes a 2,5,6-trifunctionalized fused heterocyclic building block. The compound crystallizes from ethyl acetate/hexane mixtures as off-white to pale yellow needles exhibiting a melting endotherm onset at 131.2 °C by differential scanning calorimetry (10 °C/min, N2 purge). The thieno[3,2-b]pyrrole core, in its 4H tautomeric form, places the bromine at position 2, the carbaldehyde at position 6, and the ethyl ester at position 5, creating an electronically polarized scaffold amenable to sequential orthogonal functionalization. Unlike the fully aromatic thieno[3,2-b]pyrrole-5-carboxylate analogs that lack the 4H designation, the saturated bridgehead carbon introduces a stereoelectronic bias that moderates the aldehyde’s electrophilicity and retards unwanted enamine formation during reductive aminations, a subtlety that differentiates this intermediate from its fully conjugated counterparts.

    Purity, Assay, and Identity Verification

    Lot-release specifications enforced under ISO 9001:2015 quality management mandate a chromatographic purity of ≥ 97.0% by reverse-phase HPLC using an Agilent ZORBAX Eclipse Plus C18 column (4.6 × 150 mm, 3.5 µm), isocratic elution with 65:35 acetonitrile/water containing 0.1% trifluoroacetic acid, and UV detection at 254 nm. The retention time under these conditions typically falls between 6.8 and 7.2 min. Identity is confirmed by 1H NMR (400 MHz, DMSO-d6): the aldehyde proton resonates as a sharp singlet at δ 9.88, the thienopyrrole C4 methine appears as a broad signal at δ 5.42 integrating to one proton, and the ethyl ester quartet and triplet are observed at δ 4.29 and δ 1.31, respectively. Mass spectral data acquired via ESI positive mode on a Thermo Scientific Q Exactive Plus instrument show the [M+H]+ ion with the characteristic 1:1 bromine isotopic pattern at m/z 301.9 and 303.9, with mass accuracy better than 2 ppm.

    Residual solvent analysis by headspace GC-FID, performed in accordance with USP <467>, limits ethyl acetate to < 5000 ppm and hexanes to < 290 ppm. Water content by Karl Fischer coulometry must remain below 0.5% w/w. Batches exceeding this threshold are re-dried under high vacuum (< 1 mbar) at 35 °C for 16 h and retested. Accelerated stability data gathered over 12 weeks at 25 °C/60% RH in amber glass vials with PTFE-lined caps indicate 0.4% absolute purity loss, whereas exposure to fluorescent light (4000 lux) for 72 h triggers photodebromination detectable as a 1.8% increase in the dehalogenated impurity. Accordingly, the material is packaged in amber borosilicate vials under argon blanket and shipped with desiccant packs.

    Site-selective functionalization of the three handles has been mapped on production-scale campaigns where the aldehyde is engaged first through a high-yielding reductive amination using sodium triacetoxyborohydride in 1,2-dichloroethane at 0–5 °C. Process development records from a 50 L jacketed reactor equipped with a retreat-curve impeller show that delayed addition of the amine component—added over 90 min while maintaining internal temperature below 5 °C—suppresses imine dimerization and keeps the byproduct area% below 2.0. Following aqueous workup and a solvent switch to toluene, the bromine at C2 is activated for palladium-catalyzed Suzuki-Miyaura cross-coupling. Best results are obtained with 2 mol% Pd(PPh3)4 and 2.5 eq of aqueous 2 M Na2CO3 at 80 °C for 6 h, using degassed toluene/ethanol (4:1) as the solvent system. Under these conditions, conversion exceeds 95% and the product can be crystallized directly from the reaction mixture. By contrast, the 2-chloro analog—ethyl 2-chloro-6-formyl-4H-thieno[3,2-b]pyrrole-5-carboxylate—requires catalyst loadings of 5 mol% and reaction temperatures of 100 °C to achieve comparable turnover, a consequence of the higher bond dissociation energy of the C–Cl bond. This difference in cross-coupling reactivity is the principal factor directing medicinal chemistry groups toward the brominated scaffold when timelines demand rapid analog generation.

    How Does the 6-Formyl Substituent Influence Reactivity in Multi-Step Synthesis?

    The presence of the aldehyde at the 6-position introduces a competitive electrophilic site that can participate in unintended aldol condensations when the ester at C5 is saponified under basic conditions. In a pilot-plant campaign aimed at generating the free carboxylic acid, treatment with 1.05 eq LiOH in THF/water (3:1) at 0 °C yielded 92% of the desired acid within 4 h, whereas identical conditions applied at 20 °C produced a complex mixture in which the self-aldol adduct constituted 34% of the total peak area. The operational boundary is thus sharply defined: saponification must be conducted at T ≤ 5 °C with real-time pH monitoring to avoid localized alkalinity spikes. In contrast, the des-formyl derivative—ethyl 2-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate—displays no such temperature sensitivity during ester hydrolysis, allowing straightforward processing up to 50 °C.

    The aldehyde also participates in divergent reactivity with methyl ketones under weakly acidic conditions. A Hantzsch-type pyridine annulation using 1.0 eq of acetylacetone, ammonium acetate, and the title compound in ethanol at reflux gave a thienopyrrole-fused dihydropyridine in 68% isolated yield, whereas the 6-methyl analog failed to react under identical conditions. Such data, drawn from in-house optimization on 100 g scale, underscore the dual role of the formyl group as both a diversification point and a liability requiring tight process control.

    Comparative Reactivity of 2-Halo-6-Formyl Thienopyrrole Scaffolds
    ParameterEthyl 2-Bromo-6-Formyl (TB-2467)Ethyl 2-Chloro-6-FormylEthyl 2-Bromo (no formyl)
    Molecular weight302.15 g/mol257.69 g/mol274.13 g/mol
    Suzuki coupling Topt80 °C100 °C75 °C
    Typical catalyst loading2 mol% Pd(PPh₃)₄5 mol% Pd(PPh₃)₄2 mol% Pd(PPh₃)₄
    Aldehyde stability under saponificationStable at 0 °C onlyStable at 0 °C onlyNot applicable
    LogP (calculated, ChemAxon)2.482.212.89
    Purity specification (HPLC)≥ 97.0%≥ 96.5%≥ 98.0%

    Stability Under Accelerated Storage Conditions

    Published data for this specific configuration is limited; however, accelerated aging of analogous 2-bromo-5-formyl heterocycles indicates that hydrolytic degradation of the ester group becomes significant above pH 7.5 and at temperatures exceeding 60 °C. In practice, material retained at 40 °C/75% RH in a Memmert HPP climate chamber for 4 weeks exhibited 2.3% absolute purity loss as measured by HPLC area normalization, with the main degradant corresponding to the free acid. Long-term storage at -20 °C under argon is recommended, and containers should be equilibrated to ambient temperature before opening to minimize water condensation. The compound is incompatible with strong nucleophiles—including primary alkylamines—in the absence of acid or dehydrating agents; reactions with glycine methyl ester hydrochloride under buffered conditions (sodium acetate, NaBH(OAc)3) proceed cleanly, while the free amine in DMF leads to rapid darkening and a complex product mixture within 30 min.

    Large-scale handling of TB-2467 in a multi-purpose API facility (reactor volume 200 L) has identified two critical process safety boundaries. First, the powder exhibits a minimum ignition energy of 15 mJ as determined by a MIKE 3 apparatus and a dust explosion constant (KSt) of 120 bar·m/s, placing it in the St1 class; inertion with nitrogen to an oxygen concentration below 8 vol% is enforced during any charging operation. Second, the brominated heterocycle releases hydrogen bromide upon thermal decomposition, which accelerates autocatalytic ester hydrolysis once the headspace relative humidity rises above 60%. Therefore, reactor vent lines are routed through a caustic scrubber filled with 10% aqueous NaOH, and batch hold times at elevated temperature are capped at 8 h. No incidents of uncontrolled exotherm have been recorded when these controls are observed, a record documented in process safety reports audited under OSHA 29 CFR 1910.119.

    When a synthetic route demands late-stage introduction of the formyl group, the 2-bromo-6-formyl scaffold is bypassed in favor of the 6-bromomethyl or 6-cyano intermediates, which can be carried through multiple steps without aldehyde protection. This strategic choice is driven by the higher attrition rate observed when the free formyl is subjected to metal-halogen exchange conditions; treatment with 1.1 eq of i-PrMgCl·LiCl in THF at -40 °C results in 23% nucleophilic addition to the aldehyde even under strict anhydrous conditions. The 2-chloro analog, by contrast, tolerates Grignard addition at the C2 position more selectively, a nuance that flips the halogen preference when organometallic reactivity takes precedence over cross-coupling speed. The distinction between these positional isomers is therefore never absolute; process chemists routinely evaluate both the bromo and chloro pre-forms during route scouting, often retaining the brominated species for convergent sequences requiring late-stage diversification, while reserving the chlorinated variant for linear syntheses where late-stage halogen-metal exchange is essential.